Skip to main content
Top
Published in: BMC Ophthalmology 1/2018

Open Access 01-12-2018 | Case report

Fundus changes in type III membranoproliferative glomerulonephritis: a case report

Authors: Masato Takei, Akira Obana, Takenori Inomata, Takao Tanaka, Tina Shiang, Yuan Bae, Tamiko Takemura, Akira Murakami

Published in: BMC Ophthalmology | Issue 1/2018

Login to get access

Abstract

Background

Membranoproliferative glomerulonephritis (MPGN) is characterized by mesangial cell proliferation and is classified into types I, II and III based on structural changes in the glomerular capillary walls. The drusen-like deposits of MPGN type II have been studied, but the fundus changes in MPGN type III have yet to be clarified. We report a case of MPGN type III with multiple deposits in the retinal pigment epithelium (RPE).

Case presentation

A 40-year-old Japanese woman with MPGN type III developed numerous yellow-white patches in the central macula of both eyes. Optical coherence tomography (OCT) showed deposits between the RPE and Bruch’s membrane. Fluorescein angiography showed choroidal neovascularization (CNV) and OCT confirmed it as type 1 (sub RPE) CNV with fibrin tissue and subretinal fluid in the right eye. After 12 months, the CNV and subretinal fluid resolved spontaneously but the RPE deposits remained in both eyes. Her final visual acuity was 20/20 in the right eye and 20/16 in the left eye.

Conclusion

We report a case of MPGN type III with multiple deposits in the RPE and CNV, suggesting that various fundus changes occur in MPGN type III and careful fundus follow-up is necessary to prevent vision loss.
Literature
2.
go back to reference Bomback AS, Appel GB. Pathogenesis of the C3 glomerulopathies and reclassification of MPGN. Nat Rev Nephrol. 2012;8(11):634–42.CrossRefPubMed Bomback AS, Appel GB. Pathogenesis of the C3 glomerulopathies and reclassification of MPGN. Nat Rev Nephrol. 2012;8(11):634–42.CrossRefPubMed
3.
4.
go back to reference Dalvin LA, Fervenza FC, Sethi S, Pulido JS. Shedding light on Fundus Drusen associated with Membranoproliferative Glomerulonephritis: breaking stereotypes of types I, ii, and iii. Retin Cases Brief Rep. 2016;10(1):72–8.CrossRefPubMed Dalvin LA, Fervenza FC, Sethi S, Pulido JS. Shedding light on Fundus Drusen associated with Membranoproliferative Glomerulonephritis: breaking stereotypes of types I, ii, and iii. Retin Cases Brief Rep. 2016;10(1):72–8.CrossRefPubMed
5.
go back to reference Hassenstein A, Richard G. Choroidal neovascularisation in type II membranoproliferative glomerulonephritis, photodynamic therapy as a treatment option--a case report. Klin Monatsbl Augenheilkd. 2003;220(7):492–5.CrossRefPubMed Hassenstein A, Richard G. Choroidal neovascularisation in type II membranoproliferative glomerulonephritis, photodynamic therapy as a treatment option--a case report. Klin Monatsbl Augenheilkd. 2003;220(7):492–5.CrossRefPubMed
6.
go back to reference Framme C, Herboth T, Roider J, Laqua H. Subretinal neovascular membranes in membranoproliferative glomerulonephritis type II. Klin Monatsbl Augenheilkd. 1998;213(4):252–3.CrossRefPubMed Framme C, Herboth T, Roider J, Laqua H. Subretinal neovascular membranes in membranoproliferative glomerulonephritis type II. Klin Monatsbl Augenheilkd. 1998;213(4):252–3.CrossRefPubMed
7.
go back to reference Ulbig MR, Riordan-Eva P, Holz FG, Rees HC, Hamilton PA. Membranoproliferative glomerulonephritis type II associated with central serous retinopathy. Am J Ophthalmol. 1993;116(4):410–3.CrossRefPubMed Ulbig MR, Riordan-Eva P, Holz FG, Rees HC, Hamilton PA. Membranoproliferative glomerulonephritis type II associated with central serous retinopathy. Am J Ophthalmol. 1993;116(4):410–3.CrossRefPubMed
8.
go back to reference Han DP, Sievers S. Extensive drusen in type I membranoproliferative glomerulonephritis. Arch Ophthalmol. 2009;127(4):577–9.CrossRefPubMed Han DP, Sievers S. Extensive drusen in type I membranoproliferative glomerulonephritis. Arch Ophthalmol. 2009;127(4):577–9.CrossRefPubMed
9.
go back to reference Duvall-Young J, MacDonald MK, McKechnie NM. Fundus changes in (type II) mesangiocapillary glomerulonephritis simulating drusen: a histopathological report. Br J Ophthalmol. 1989;73(4):297–302.CrossRefPubMedPubMedCentral Duvall-Young J, MacDonald MK, McKechnie NM. Fundus changes in (type II) mesangiocapillary glomerulonephritis simulating drusen: a histopathological report. Br J Ophthalmol. 1989;73(4):297–302.CrossRefPubMedPubMedCentral
10.
go back to reference Duvall-Young J, Short CD, Raines MF, Gokal R, Lawler W. Fundus changes in mesangiocapillary glomerulonephritis type II: clinical and fluorescein angiographic findings. Br J Ophthalmol. 1989;73(11):900–6.CrossRefPubMedPubMedCentral Duvall-Young J, Short CD, Raines MF, Gokal R, Lawler W. Fundus changes in mesangiocapillary glomerulonephritis type II: clinical and fluorescein angiographic findings. Br J Ophthalmol. 1989;73(11):900–6.CrossRefPubMedPubMedCentral
11.
go back to reference Michielsen B, Leys A, Van Damme B, Missotten L. Fundus changes in chronic membranoproliferative glomerulonephritis type II. Doc Ophthalmol. 1990;76(3):219–29.CrossRefPubMed Michielsen B, Leys A, Van Damme B, Missotten L. Fundus changes in chronic membranoproliferative glomerulonephritis type II. Doc Ophthalmol. 1990;76(3):219–29.CrossRefPubMed
12.
go back to reference Woo SA, Young Ju H, Hyo Kwon S, Lee JH, Jeong Choi S, Cheol Han D, Duk Hwang S, Hong SY, Jin SY, Gil HW. Reanalysis of membranoproliferative glomerulonephritis patients according to the new classification: a multicenter study. Kidney Res Clin Pract. 2014;33(4):187–91.CrossRefPubMedPubMedCentral Woo SA, Young Ju H, Hyo Kwon S, Lee JH, Jeong Choi S, Cheol Han D, Duk Hwang S, Hong SY, Jin SY, Gil HW. Reanalysis of membranoproliferative glomerulonephritis patients according to the new classification: a multicenter study. Kidney Res Clin Pract. 2014;33(4):187–91.CrossRefPubMedPubMedCentral
13.
go back to reference Dalvin LA, Fervenza FC, Sethi S, Pulido JS. Manifestations of complement-mediated and immune complex-mediated Membranoproliferative Glomerulonephritis: a comparative consecutive series. Ophthalmology. 2016;123(7):1588–94.CrossRefPubMed Dalvin LA, Fervenza FC, Sethi S, Pulido JS. Manifestations of complement-mediated and immune complex-mediated Membranoproliferative Glomerulonephritis: a comparative consecutive series. Ophthalmology. 2016;123(7):1588–94.CrossRefPubMed
14.
go back to reference Mullins RF, Aptsiauri N, Hageman GS. Structure and composition of drusen associated with glomerulonephritis: implications for the role of complement activation in drusen biogenesis. Eye. 2001;15(Pt 3):390–5.CrossRefPubMed Mullins RF, Aptsiauri N, Hageman GS. Structure and composition of drusen associated with glomerulonephritis: implications for the role of complement activation in drusen biogenesis. Eye. 2001;15(Pt 3):390–5.CrossRefPubMed
15.
go back to reference Kim DD, Mieler WF, Wolf MD. Posterior segment changes in membranoproliferative glomerulonephritis. Am J Ophthalmol. 1992;114(5):593–9.CrossRefPubMed Kim DD, Mieler WF, Wolf MD. Posterior segment changes in membranoproliferative glomerulonephritis. Am J Ophthalmol. 1992;114(5):593–9.CrossRefPubMed
16.
go back to reference Leys A, Michielsen B, Leys M, Vanrenterghem Y, Missotten L, Van Damme B. Subretinal neovascular membranes associated with chronic membranoproliferative glomerulonephritis type II. Graefes Arch Clin Exp Ophthalmol. 1990;228(6):499–504.CrossRefPubMed Leys A, Michielsen B, Leys M, Vanrenterghem Y, Missotten L, Van Damme B. Subretinal neovascular membranes associated with chronic membranoproliferative glomerulonephritis type II. Graefes Arch Clin Exp Ophthalmol. 1990;228(6):499–504.CrossRefPubMed
17.
go back to reference McCullagh D, Silvestri G, Maxwell AP. Treatment of choroidal neovascularisation secondary to membranoproliferative glomerulonephritis type II with intravitreal ranibizumab. BMJ Case Rep. 2014;2014. McCullagh D, Silvestri G, Maxwell AP. Treatment of choroidal neovascularisation secondary to membranoproliferative glomerulonephritis type II with intravitreal ranibizumab. BMJ Case Rep. 2014;2014.
18.
go back to reference Empeslidis T, Imrani U, Vardarinos A, Menassa N, Banerjee S. Spontaneous resolution of retinal pigment epithelial detachments and visual improvement in patient with MPGN II: a case report. Case Rep Ophthalmol Med. 2012;2012:864198.PubMedPubMedCentral Empeslidis T, Imrani U, Vardarinos A, Menassa N, Banerjee S. Spontaneous resolution of retinal pigment epithelial detachments and visual improvement in patient with MPGN II: a case report. Case Rep Ophthalmol Med. 2012;2012:864198.PubMedPubMedCentral
Metadata
Title
Fundus changes in type III membranoproliferative glomerulonephritis: a case report
Authors
Masato Takei
Akira Obana
Takenori Inomata
Takao Tanaka
Tina Shiang
Yuan Bae
Tamiko Takemura
Akira Murakami
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Ophthalmology / Issue 1/2018
Electronic ISSN: 1471-2415
DOI
https://doi.org/10.1186/s12886-018-0738-x

Other articles of this Issue 1/2018

BMC Ophthalmology 1/2018 Go to the issue